China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294.SZ)
CNY 26.55
(-0.19%)
CNY 26.55
(-0.19%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 556.94 Million CNY | -16.5% |
| 2022 | 666.96 Million CNY | -1.46% |
| 2021 | 676.83 Million CNY | -1.83% |
| 2020 | 689.46 Million CNY | 10.95% |
| 2019 | 621.4 Million CNY | 2.81% |
| 2018 | 604.43 Million CNY | 16.77% |
| 2017 | 517.63 Million CNY | 79.29% |
| 2016 | 288.71 Million CNY | 34.68% |
| 2015 | 214.37 Million CNY | 68.1% |
| 2014 | 127.52 Million CNY | 9.89% |
| 2013 | 116.04 Million CNY | 29.89% |
| 2012 | 89.33 Million CNY | 4.54% |
| 2011 | 85.45 Million CNY | 7.74% |
| 2010 | 79.32 Million CNY | 64.42% |
| 2009 | 48.24 Million CNY | -11.96% |
| 2008 | 54.79 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 627.57 Million CNY | 8.71% |
| 2024 Q2 | 577.32 Million CNY | 1.91% |
| 2024 Q1 | 566.51 Million CNY | 1.72% |
| 2023 Q4 | 556.94 Million CNY | -3.93% |
| 2023 FY | 556.94 Million CNY | -16.5% |
| 2023 Q1 | 617.81 Million CNY | -7.37% |
| 2023 Q2 | 581.97 Million CNY | -5.8% |
| 2023 Q3 | 579.7 Million CNY | -0.39% |
| 2022 FY | 666.96 Million CNY | -1.46% |
| 2022 Q1 | 670.3 Million CNY | -0.96% |
| 2022 Q2 | 660.29 Million CNY | -1.49% |
| 2022 Q3 | 656.92 Million CNY | -0.51% |
| 2022 Q4 | 666.96 Million CNY | 1.53% |
| 2021 Q3 | 613.42 Million CNY | -6.76% |
| 2021 Q2 | 657.9 Million CNY | -4.29% |
| 2021 FY | 676.83 Million CNY | -1.83% |
| 2021 Q1 | 687.41 Million CNY | -0.3% |
| 2021 Q4 | 676.83 Million CNY | 10.34% |
| 2020 Q2 | 658.81 Million CNY | -0.54% |
| 2020 Q1 | 662.39 Million CNY | 6.6% |
| 2020 FY | 689.46 Million CNY | 10.95% |
| 2020 Q3 | 699.36 Million CNY | 6.15% |
| 2020 Q4 | 689.46 Million CNY | -1.42% |
| 2019 Q1 | 639.4 Million CNY | 5.79% |
| 2019 Q3 | 649.34 Million CNY | 4.1% |
| 2019 Q4 | 621.4 Million CNY | -4.3% |
| 2019 FY | 621.4 Million CNY | 2.81% |
| 2019 Q2 | 623.8 Million CNY | -2.44% |
| 2018 Q3 | 587.53 Million CNY | 8.58% |
| 2018 FY | 604.43 Million CNY | 16.77% |
| 2018 Q2 | 541.09 Million CNY | -1.39% |
| 2018 Q1 | 548.72 Million CNY | 6.01% |
| 2018 Q4 | 604.43 Million CNY | 2.88% |
| 2017 Q4 | 517.63 Million CNY | 22.02% |
| 2017 Q3 | 424.21 Million CNY | 5.34% |
| 2017 Q1 | 335.93 Million CNY | 16.36% |
| 2017 Q2 | 402.69 Million CNY | 19.87% |
| 2017 FY | 517.63 Million CNY | 79.29% |
| 2016 Q4 | 288.71 Million CNY | 6.59% |
| 2016 Q2 | 262.11 Million CNY | 10.07% |
| 2016 FY | 288.71 Million CNY | 34.68% |
| 2016 Q1 | 238.12 Million CNY | 11.08% |
| 2016 Q3 | 270.85 Million CNY | 3.34% |
| 2015 Q2 | 147 Million CNY | 5.95% |
| 2015 Q1 | 138.75 Million CNY | 8.8% |
| 2015 Q4 | 214.37 Million CNY | 32.98% |
| 2015 FY | 214.37 Million CNY | 68.1% |
| 2015 Q3 | 161.2 Million CNY | 9.66% |
| 2014 FY | 127.52 Million CNY | 9.89% |
| 2014 Q2 | 122.48 Million CNY | 5.09% |
| 2014 Q4 | 127.52 Million CNY | -3.84% |
| 2014 Q3 | 132.61 Million CNY | 8.27% |
| 2014 Q1 | 116.54 Million CNY | 0.43% |
| 2013 Q2 | 96.4 Million CNY | 3.68% |
| 2013 FY | 116.04 Million CNY | 29.89% |
| 2013 Q4 | 116.04 Million CNY | 18.8% |
| 2013 Q3 | 97.67 Million CNY | 1.32% |
| 2013 Q1 | 92.98 Million CNY | 4.08% |
| 2012 FY | 89.33 Million CNY | 4.54% |
| 2012 Q2 | 88.93 Million CNY | 2.6% |
| 2012 Q1 | 86.68 Million CNY | 1.43% |
| 2012 Q4 | 89.33 Million CNY | -0.1% |
| 2012 Q3 | 89.43 Million CNY | 0.55% |
| 2011 FY | 85.45 Million CNY | 7.74% |
| 2011 Q4 | 85.45 Million CNY | 0.0% |
| 2010 FY | 79.32 Million CNY | 64.42% |
| 2009 FY | 48.24 Million CNY | -11.96% |
| 2008 FY | 54.79 Million CNY | 0.0% |